Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombin active site inhibitors

J Das1, S D Kimball

  • 1Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000, USA.

Bioorganic & Medicinal Chemistry
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards modelling mental disorders in zebrafish. Neurexins severely modulate anxiety, affiliative social behaviour and aggression.

Molecular psychiatry·2026
Same author

Comparison of PET-CT and contrast-enhanced CT in the evaluation of recurrent oral squamous cell carcinoma.

International journal of oral and maxillofacial surgery·2026
Same author

Multimodal machine learning mobility assessment in Parkinson's disease within supervised and unsupervised settings.

Journal of neuroengineering and rehabilitation·2026
Same author

Multi-modal gait assessment in Parkinson's Disease: A pilot study examining the impact of terrain and environment.

Gait & posture·2026
Same author

Active-reset protein sensors enable continuous in vivo monitoring of inflammation.

Science (New York, N.Y.)·2024
Same author

Field tuning Kitaev systems for spin fractionalization and topological order.

Journal of physics. Condensed matter : an Institute of Physics journal·2024

Small molecule inhibitors targeting the thrombin active site are under development. This review covers recent advancements and remaining challenges in this research area.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Thrombin is a key enzyme in blood coagulation.
  • Inhibiting thrombin can prevent thrombosis.
  • Small molecules offer targeted therapeutic approaches.

Purpose of the Study:

  • To review recent progress in small molecule thrombin active site inhibitors.
  • To outline the challenges in developing these inhibitors.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of structure-activity relationships.
  • Discussion of pharmacokinetic and pharmacodynamic properties.

Main Results:

  • Several classes of small molecule inhibitors have been identified.

Related Experiment Videos

  • Progress has been made in optimizing potency and selectivity.
  • Challenges remain in achieving desired in vivo efficacy and safety profiles.

    • Conclusions:

    • Small molecule thrombin inhibitors represent a promising therapeutic strategy.
    • Further research is needed to overcome existing challenges for clinical translation.